Literature DB >> 9491897

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

T Sakurai1, A Amemiya, M Ishii, I Matsuzaki, R M Chemelli, H Tanaka, S C Williams, J A Richardson, G P Kozlowski, S Wilson, J R Arch, R E Buckingham, A C Haynes, S A Carr, R S Annan, D E McNulty, W S Liu, J A Terrett, N A Elshourbagy, D J Bergsma, M Yanagisawa.   

Abstract

The hypothalamus plays a central role in the integrated control of feeding and energy homeostasis. We have identified two novel neuropeptides, both derived from the same precursor by proteolytic processing, that bind and activate two closely related (previously) orphan G protein-coupled receptors. These peptides, termed orexin-A and -B, have no significant structural similarities to known families of regulatory peptides. prepro-orexin mRNA and immunoreactive orexin-A are localized in neurons within and around the lateral and posterior hypothalamus in the adult rat brain. When administered centrally to rats, these peptides stimulate food consumption. prepro-orexin mRNA level is up-regulated upon fasting, suggesting a physiological role for the peptides as mediators in the central feedback mechanism that regulates feeding behavior.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491897     DOI: 10.1016/s0092-8674(00)80949-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  1163 in total

Review 1.  [Pathophysiology of catabolism in undernurished elderly patients].

Authors:  D Baez-Franceschi; J E Morley
Journal:  Z Gerontol Geriatr       Date:  1999-07       Impact factor: 1.281

2.  SB-334867-A: the first selective orexin-1 receptor antagonist.

Authors:  D Smart; C Sabido-David; S J Brough; F Jewitt; A Johns; R A Porter; J C Jerman
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

3.  Conformational ensembles: the role of neuropeptide structures in receptor binding.

Authors:  A S Edison; E Espinoza; C Zachariah
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

4.  Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.

Authors:  P Bourgin; S Huitrón-Résendiz; A D Spier; V Fabre; B Morte; J R Criado; J G Sutcliffe; S J Henriksen; L de Lecea
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 5.  Promising new approaches to the management of obesity.

Authors:  I L Mertens; L F Van Gaal
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

6.  Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.

Authors:  Dan Georgescu; Venetia Zachariou; Michel Barrot; Michihiro Mieda; Jon T Willie; Amelia J Eisch; Masashi Yanagisawa; Eric J Nestler; Ralph J DiLeone
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

7.  Differential orexin/hypocretin expression in addiction-prone and -resistant rats selectively bred for high (HiS) and low (LoS) saccharin intake.

Authors:  Nathan A Holtz; Natalie E Zlebnik; Marilyn E Carroll
Journal:  Neurosci Lett       Date:  2012-06-02       Impact factor: 3.046

Review 8.  The Hypothalamic Preoptic Area and Body Weight Control.

Authors:  Sangho Yu; Marie François; Clara Huesing; Heike Münzberg
Journal:  Neuroendocrinology       Date:  2017-08-10       Impact factor: 4.914

9.  The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia.

Authors:  Yuko Fukunaka; Takahiro Shinkai; Rudi Hwang; Hiroko Hori; Kensuke Utsunomiya; Shinichi Sakata; Yui Naoe; Kazuko Shimizu; Chima Matsumoto; Osamu Ohmori; Jun Nakamura
Journal:  Neuromolecular Med       Date:  2007-08-01       Impact factor: 3.843

10.  Orexin inputs to caudal raphé neurons involved in thermal, cardiovascular, and gastrointestinal regulation.

Authors:  Hans-Rudolf Berthoud; Laurel M Patterson; Gregory M Sutton; Christopher Morrison; Huiyuan Zheng
Journal:  Histochem Cell Biol       Date:  2005-03-02       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.